Literature DB >> 30457473

Effects of Herbal Formulas Bojungikgi-tang and Palmijihwang-hwan on Inflammation in RAW 264.7 Cells and the Activities of Drug-Metabolizing Enzymes in Human Hepatic Microsomes.

Seong Eun Jin1, Hyekyung Ha1, Hyeun-Kyoo Shin1.   

Abstract

In the present study, Bojungikgi-tang (BJIKT: Buzhongyiqi-tang, Hochuekki-to) and Palmijihwang-hwan (PMJHH: Baweidìhuang-wan, Hachimijio-gan), traditional herbal formulas, investigated anti-inflammatory efficacies in murine macrophage cell line and the influence on the activities of drug-metabolizing enzymes (DMEs). The anti-inflammatory potentials of the herbal formulas were evaluated to inhibit the production of the inflammatory mediators and cytokines and the protein expression of inducible nitric oxide and cyclooxygenase-2 (COX-2) in lipopolysaccharide (LPS)-treated RAW 264.7 cells. The activities of the major human DMEs, cytochrome P450 isozymes (CYP450s) and UDP-glucuronosyltransferase isozymes (UGTs), were measured by in vitro enzyme assay systems. BJIKT and PMJHH significantly suppressed the prostaglandin E2 (PGE2) production (IC50 = 317.3 and 282.2 μg/mL, respectively) and the protein expression of COX-2 in LPS-treated RAW264.7 cells. On the human microsomal DMEs, BJIKT inhibited the activities of CYP1A2 (IC50 = 535.05 μg/mL), CYP2B6 (IC50 > 1000 μg/mL), CYP2C9 (IC50 = 800.78 μg/mL), CYP2C19 (IC50 = 563.11 μg/mL), CYP2D6 (IC50 > 1000 μg/mL), CYP2E1 (IC50 > 1000 μg/mL), CYP3A4 (IC50 = 879.60 μg/mL), UGT1A1 (IC50 > 1000 μg/mL), and UGT1A4 (IC50 > 1000 μg/mL), but it showed no inhibition of the UGT2B7 activity at doses less than 1000 μg/mL. PMJHH inhibited the CYP2D6 activity (IC50 = 280.89 μg/mL), but IC50 values of PMJHH exceeded 1000 μg/mL on the activities of CYP1A2, CYP2C19, CYP2E1, and CYP3A4. At concentrations less than 1000 μg/mL, PMJHH did not affect the activities of CYP2B6, CYP2C9, UGT1A1, UGT1A4, and UGT2B7. The results indicate that both BJIKT and PMJHH may be potential candidates to prevent and treat PGE2- and COX-2-mediated inflammatory diseases. In addition, this study will expand current knowledge about herb-drug interactions by BJIKT and PMJHH.

Entities:  

Keywords:  UDP-glucuronosyltransferase; anti-inflammation; cytochrome P450 (CYP450); herbal formulas; herb–drug interactions

Mesh:

Substances:

Year:  2018        PMID: 30457473     DOI: 10.1089/jmf.2017.4123

Source DB:  PubMed          Journal:  J Med Food        ISSN: 1096-620X            Impact factor:   2.786


  4 in total

1.  Live-Imaging Analysis of Target Vessels and Nitric Oxide Production Associated with Gosha-Jinki-Gan and Keishi-Bukuryo-Gan: Two Herbal Preparations with Clinically Proven Blood Flow-Improving Effects but with Different Traditional Clinical Indicative Patterns.

Authors:  Aki Hirayama; Tsutomu Tomita; Takashi Nishida; Yumiko Nagano
Journal:  Evid Based Complement Alternat Med       Date:  2022-05-11       Impact factor: 2.650

2.  Protective effect of Palmijihwanghwan in a mouse model of cigarette smoke and lipopolysaccharide-induced chronic obstructive pulmonary disease.

Authors:  Eun Bok Baek; Jin-Hyung Rho; Eunhye Jung; Chang-Seob Seo; Jin-Hee Kim; Hyo-Jung Kwun
Journal:  BMC Complement Med Ther       Date:  2021-11-16

3.  Combination therapy with tamsulosin and traditional herbal medicine for lower urinary tract symptoms due to benign prostatic hyperplasia: A double-blinded, randomized, pilot clinical trial.

Authors:  Chung Lyul Lee; Hyeun-Kyoo Shin; Ji Yong Lee; Ojin Kwon; Chang-Seob Seo; Ae-Ran Kim; Bok-Nam Seo; Seung Woo Yang; Ki Hak Song; Jae Sung Lim; Jong Mok Park; Yong Gil Na; Ju Hyun Shin
Journal:  Int J Urol       Date:  2022-03-16       Impact factor: 2.896

4.  Combined Treatment with Herbal Medicine and Drug Ameliorates Inflammation and Metabolic Abnormalities in the Liver of an Amyotrophic Lateral Sclerosis Mouse Model.

Authors:  Hee Ra Park; Eun Jin Yang
Journal:  Antioxidants (Basel)       Date:  2022-01-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.